Helius Medical Technologies (HSDT) Stock Price, News & Analysis

-0.26 (-5.13%)
(As of 09:32 AM ET)
Today's Range
50-Day Range
52-Week Range
924 shs
Average Volume
328,001 shs
Market Capitalization
$4.28 million
P/E Ratio
Dividend Yield
Price Target

Helius Medical Technologies MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
1,007.7% Upside
$54.50 Price Target
Short Interest
8.53% of Float Sold Short
Dividend Strength
News Sentiment
0.00mentions of Helius Medical Technologies in the last 14 days
Based on 3 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($7.42) to ($2.20) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.26 out of 5 stars

HSDT stock logo

About Helius Medical Technologies Stock (NASDAQ:HSDT)

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

HSDT Stock Price History

HSDT Stock News Headlines

Helius Medical Technologies, Inc. (HSDT)
At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
Helius Medical Technologies Inc.
At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
Q4 2023 Helius Medical Technologies Inc Earnings Call
Helius Medical Technologies Inc Class A (HSDT)
See More Headlines
Receive HSDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Electromedical equipment
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$3.32 per share


Free Float
Market Cap
$4.38 million
Not Optionable

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

HSDT Stock Analysis - Frequently Asked Questions

Should I buy or sell Helius Medical Technologies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Helius Medical Technologies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" HSDT shares.
View HSDT analyst ratings
or view top-rated stocks.

What is Helius Medical Technologies' stock price target for 2024?

1 equities research analysts have issued twelve-month price objectives for Helius Medical Technologies' stock. Their HSDT share price targets range from $24.00 to $85.00. On average, they predict the company's stock price to reach $54.50 in the next twelve months. This suggests a possible upside of 1,007.7% from the stock's current price.
View analysts price targets for HSDT
or view top-rated stocks among Wall Street analysts.

How have HSDT shares performed in 2024?

Helius Medical Technologies' stock was trading at $8.04 at the beginning of 2024. Since then, HSDT shares have decreased by 38.8% and is now trading at $4.92.
View the best growth stocks for 2024 here

Are investors shorting Helius Medical Technologies?

Helius Medical Technologies saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 72,200 shares, a decrease of 35.4% from the March 15th total of 111,800 shares. Based on an average daily volume of 391,300 shares, the days-to-cover ratio is presently 0.2 days. Approximately 8.5% of the shares of the stock are sold short.
View Helius Medical Technologies' Short Interest

When is Helius Medical Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our HSDT earnings forecast

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies, Inc. (NASDAQ:HSDT) issued its quarterly earnings results on Thursday, March, 28th. The company reported ($1.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.05) by $2.58. The business had revenue of $0.13 million for the quarter, compared to the consensus estimate of $0.18 million. Helius Medical Technologies had a negative trailing twelve-month return on equity of 221.11% and a negative net margin of 1,374.22%.

When did Helius Medical Technologies' stock split?

Helius Medical Technologies's stock reverse split before market open on Thursday, August 17th 2023. The 1-50 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

How do I buy shares of Helius Medical Technologies?

Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HSDT) was last updated on 4/23/2024 by Staff

From Our Partners